Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.
In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $204.31, denoting a -1.47% move from the preceding trading day.
Coca-Cola raised its dividend by 5.2% in 2025, extending its streak to 63 straight years. Kimberly-Clark's 3.3% raise last year pushed its dividend growth streak to 53 consecutive years.
LLY, MDT, ISRG, REGN and JNJ are five defensive medical stocks using AI to drive growth, diagnostics and innovation into 2026.
Econ Financial Services Corp trimmed its position in Johnson and Johnson (NYSE: JNJ) by 25.5% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11
First Pacific Financial increased its holdings in Johnson and Johnson (NYSE: JNJ) by 22.6% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exch
Golden State Equity Partners grew its position in shares of Johnson and Johnson (NYSE: JNJ) by 20.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange
Ninety One SA PTY Ltd lessened its stake in Johnson and Johnson (NYSE: JNJ) by 22.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange C
Financial Consulate Inc. bought a new stake in Johnson and Johnson (NYSE: JNJ) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commis
Ninety One UK Ltd reduced its stake in Johnson and Johnson (NYSE: JNJ) by 5.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commiss
Delta Investment Management LLC increased its holdings in Johnson and Johnson (NYSE: JNJ) by 63.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Co

2 Healthcare Stocks to Buy in a Bear Market

09:15am, Saturday, 03'rd Jan 2026
Johnson & Johnson and Abbott Laboratories are diversified healthcare companies with attractive prospects. Both have raised their dividends for over 50 consecutive years.
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter
VIRGINIA RETIREMENT SYSTEMS ET Al lifted its position in Johnson and Johnson (NYSE: JNJ) by 12.3% in the undefined quarter, according to the company in its most recent disclosure with the Securities a
NextEra Energy has grown its dividend at a 10% compound annual rate over the past 20 years. Realty Income has increased its dividend for more than 30 consecutive years.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE